Author

Яворская Марина Алексеевна

Observed names: M. A. Yavorskaya, Marina A. Yavorskaya, Marina Yavorskaya

Institution: Oncological Dispensary No. 2

Observed institution: Oncological Dispensary No. 2

ORCID: 0009-0001-4149-5252

Observed ORCID: 0009-0001-4149-5252

OpenAlex ID: A5003720874

Efficacy of atezolizumab in patients resistant to platinum-based chemotherapy. Results of the AURORA-RU Study: Atezolizumab in UROthelial cancer: Real-world Analysis of RUssia

2026 · Evgeniy A. Usynin, O. V. Leonov, et al. · Cancer Urology · 1

Intermediate results of the PERFECTION observational study in a population of patients with metastatic, persistent and recurrent cervical cancer

2025 · Valeria V. Saevets, Nikita K. Kuzmin, et al. · Journal of Modern Oncology · 1

Incidence of severe and febrile neutropenia in cancer patients treated with myelosuppressive chemotherapy in real clinical oncology practice: Preliminary results from the FLAME study.

2022 · Anton Snegovoy, Inessa Kononenko, et al. · Journal of Clinical Oncology · 1

Key results of a multicenter, non-interventional, retrospective study of Ixabepilone therapy in routine clinical practice in patients with locally advanced or metastatic breast cancer after failure of previous therapy NIRMA

2025 · E. V. Artamonova, E. P. Anokhina, et al. · Medical alphabet

Final data on the eﬃcacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world eﬃcacy of prolgolimab in patients with metastatic melanoma in Russia

2024 · Kristina V. Orlova, Mikhail Fedyanin, et al. · Journal of Modern Oncology

Промежуточные результаты наблюдательного исследования PERFECTION в популяции пациенток с метастатическим, персистирующим и рецидивирующим раком шейки матки

· Саевец Валерия Владимировна, Кузьмин Никита Константинович, et al. · CyberLeninK (CyberLeninka)

Works count: 8

Citation count: 3

H-index: 1

I10-index: